biguanides has been researched along with Diabetic Glomerulosclerosis in 9 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of type 2 diabetes in a patient with CRF is a challenge for the general practitioner, because of the accumulation of drugs and/or specific metabolites." | 2.44 | [Chronic kidney disease and antidiabetic treatment]. ( Berwert, L; Teta, D; Zanchi, A, 2007) |
| "The biguanides are a class of oral hypoglycemic agents that are commonly used in the treatment of diabetes mellitus." | 2.38 | Biguanide-associated lactic acidosis. Case report and review of the literature. ( Arieff, AI; Barr, J; Gan, SC; Pearl, RG, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saha, SA | 1 |
| Tuttle, KR | 1 |
| Flynn, C | 1 |
| Bakris, GL | 1 |
| Yamagata, K | 1 |
| Andou, J | 1 |
| Amiya, E | 1 |
| Eguchi, K | 1 |
| Hatano, M | 1 |
| Hosoya, Y | 1 |
| Sibagaki, Y | 1 |
| Morita, T | 1 |
| Nagai, R | 1 |
| Berwert, L | 1 |
| Teta, D | 1 |
| Zanchi, A | 1 |
| Haslbeck, M | 1 |
| Gan, SC | 1 |
| Barr, J | 1 |
| Arieff, AI | 1 |
| Pearl, RG | 1 |
| Ziegelasch, HJ | 1 |
| Oakley, WG | 1 |
| Takác, A | 1 |
| Lüdtke, E | 1 |
5 reviews available for biguanides and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
Topics: Acarbose; Biguanides; Cardiovascular Diseases; Combined Modality Therapy; Contraindications; Diabete | 2010 |
Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Dise | 2013 |
[Chronic kidney disease and antidiabetic treatment].
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chron | 2007 |
[New aspects of therapy with oral antidiabetic agents].
Topics: Acidosis; Biguanides; Blood Proteins; Chlorpropamide; Diabetes Mellitus; Diabetic Nephropathies; Dru | 1979 |
Biguanide-associated lactic acidosis. Case report and review of the literature.
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Emigration and Immi | 1992 |
4 other studies available for biguanides and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[A persistent shock state with severe lactic acidosis, after increasing biguanaide to a diabetic patient with renal impairment].
Topics: Acidosis, Lactic; Aged; Biguanides; Diabetes Mellitus; Diabetic Nephropathies; Humans; Male; Shock | 2006 |
[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
Topics: Age Factors; Aged; Biguanides; Chloramphenicol; Diabetes Mellitus; Diabetic Angiopathies; Diabetic N | 1972 |
The management of diabetes over one-third of a century.
Topics: Biguanides; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Dietary Carbohydrates; | 1971 |
[On the influence on transport processes in the kidney by N-1,n-butylbiguanide].
Topics: Aminohippuric Acids; Animals; Biguanides; Caproates; Diabetic Nephropathies; Glucose; Humans; Inulin | 1966 |